Primary indications for When to start antiepileptic drugs (AEDs)

---

Seizures are a common neurological condition, and antiepileptic drugs (AEDs) play a critical role in the prevention of further episodes. However, the decision to initiate AED therapy is not always straightforward and must be based on a careful assessment of the underlying cause, risk of recurrence, and other clinical factors. This article provides an in-depth, yet easy-to-understand, guide on the primary indications for starting AEDs, aimed at internal medicine practitioners and students seeking to deepen their knowledge.

1. Two or More Unprovoked Seizures

One of the most clear-cut indications for initiating AED therapy is when a patient has experienced two or more unprovoked seizures. Unprovoked seizures are defined as those that occur without an acute or reversible cause, such as fever, drug withdrawal, or electrolyte imbalance. These types of seizures suggest a high likelihood of an underlying epileptic condition.

Why Two or More?

• Studies have shown that after two unprovoked seizures, the risk of future seizures is significantly elevated, often exceeding 60%. This risk justifies the use of AEDs to prevent further seizures and reduce the associated risks, such as injury, cognitive impairment, and sudden unexpected death in epilepsy (SUDEP).

• Unprovoked seizures are usually considered a sign of a chronic neurological disorder—epilepsy—where the brain has an enduring predisposition to generate seizures.

2. One Unprovoked Seizure with High Risk of Recurrence

In some cases, AEDs may be considered after a single unprovoked seizure, particularly if the patient is at high risk of recurrence. Several clinical factors help determine this risk, and if the likelihood of further seizures is similar to that of someone with two unprovoked seizures, starting AEDs may be warranted. Here are the major risk factors for recurrence:

A. Traumatic Brain Injury (TBI):

• TBI, especially moderate to severe, significantly increases the risk of developing post-traumatic epilepsy (PTE). The risk can range from 2% in mild cases to over 25% in severe TBIs.

• Early seizures following TBI (within the first week) are a strong predictor of future seizures. Initiating AEDs in patients with a history of TBI can prevent further seizure episodes and improve long-term outcomes.

B. Abnormal EEG Findings:

• An electroencephalogram (EEG) is a powerful tool in assessing seizure risk. Epileptiform abnormalities such as spikes, sharp waves, or focal slowing are strong indicators of an increased likelihood of future seizures.

• Patients with abnormal EEG patterns following a single seizure have a risk of recurrence approaching 60%, which is similar to the risk seen in patients with two unprovoked seizures.

C. Structural Brain Abnormalities:

• Imaging studies such as MRI or CT that reveal structural lesions, such as from prior strokes, brain tumors, congenital malformations, or cortical dysplasias, are significant predictors of recurrent seizures.

• Patients with such abnormalities are more likely to benefit from early AED therapy to prevent seizures from occurring again.

D. Neurosurgery:

• Patients who have undergone brain surgery, particularly involving the temporal lobes or cortical areas associated with seizure generation, are at high risk for postoperative seizures.

• Prophylactic AED therapy in these patients may be initiated to reduce the risk of early postoperative seizures and long-term epilepsy.

E. Genetic Predisposition:

• A family history of epilepsy or certain genetic mutations known to be associated with epilepsy syndromes can also increase the risk of recurrent seizures. In these cases, even a single unprovoked seizure may warrant AED therapy to prevent further episodes.

3. Diagnosis of an Epilepsy Syndrome

Patients who are diagnosed with a specific epilepsy syndrome typically require AEDs as part of their treatment plan. Epilepsy syndromes are characterized by a constellation of clinical features, including seizure types, age of onset, and specific EEG patterns, which help in making a definitive diagnosis. Some common epilepsy syndromes where AEDs are often indicated include:

• Childhood Absence Epilepsy: Characterized by frequent absence seizures, AEDs like ethosuximide or valproate are essential for seizure control.

• Juvenile Myoclonic Epilepsy (JME): This syndrome is marked by myoclonic jerks, generalized tonic-clonic seizures, and absence seizures. AEDs such as valproate or levetiracetam are typically prescribed as part of the long-term management plan.

Early diagnosis and treatment of epilepsy syndromes are critical to controlling seizures and improving patients' quality of life. AEDs are almost always indicated in these cases to prevent frequent and potentially harmful seizures.

4. Status Epilepticus

Status epilepticus is a neurological emergency that involves prolonged seizure activity lasting more than 5 minutes or repeated seizures without a return to baseline consciousness. Immediate intervention with AEDs is required to stop the ongoing seizure activity and prevent neurological damage or death. After the acute episode is controlled, long-term AED therapy is often necessary to prevent future episodes.

Why Is Status Epilepticus an Indication for AEDs?

• The risk of recurrence is high, and these prolonged seizures can lead to neuronal injury, cognitive decline, and even death if left untreated.

• In many cases, patients who experience status epilepticus are already at risk for recurrent seizures, and the event may be a trigger for starting long-term AED therapy to prevent further complications.

Risk of Recurrence in Seizures

Understanding the risk of recurrence after a seizure is crucial for deciding whether to start AEDs. Studies suggest that the risk of a second seizure within 10 years of an initial unprovoked seizure is between 40-60%, depending on risk factors. Those with TBI, structural brain abnormalities, abnormal EEG, or a family history of epilepsy have a significantly higher chance of recurrence.

For example:

• Traumatic Brain Injury (TBI): The risk of developing epilepsy increases with the severity of the injury. Severe TBIs may carry a risk as high as 25%, making AED initiation in these patients highly recommended.

• Neurosurgical Patients: Patients who have undergone brain surgery, particularly for tumor resection or aneurysms, are at high risk for seizures, especially in the postoperative period. In such cases, starting AED therapy may be crucial for preventing seizures and managing the patient's recovery.

Conclusion

In summary, AED therapy is typically initiated in patients with two or more unprovoked seizures, a single unprovoked seizure with a high risk of recurrence (such as those with traumatic brain injury, structural abnormalities, or abnormal EEG findings), those diagnosed with specific epilepsy syndromes, and after an episode of status epilepticus. Internal medicine practitioners must carefully assess the individual risk factors in each case and make informed decisions about when to start AEDs, balancing the risks of untreated seizures with potential side effects of the medication.